United States (US) Non-steroidal Anti-inflammatory Drugs Market (2025-2031) | Value, Outlook, Share, Segmentation, Growth, Size & Revenue, Analysis, Industry, Forecast, Competitive Landscape, Companies, Trends

Name: United States (US) Non-steroidal Anti-inflammatory Drugs Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Route of Administration (Oral, Parenteral, Topical), By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Competitive Landscape

Product Code: ETC9971649	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Non-steroidal Anti-inflammatory Drugs Market Outlook
Market Size of United States (US) Non-steroidal Anti-inflammatory Drugs Market, 2024
Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market, 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Revenues & Volume for the Period 2021- 2031
United States (US) Non-steroidal Anti-inflammatory Drugs Market Trend Evolution
United States (US) Non-steroidal Anti-inflammatory Drugs Market Drivers and Challenges
United States (US) Non-steroidal Anti-inflammatory Drugs Price Trends
United States (US) Non-steroidal Anti-inflammatory Drugs Porter's Five Forces
United States (US) Non-steroidal Anti-inflammatory Drugs Industry Life Cycle
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Oral for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Parenteral for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Topical for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Disease Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Arthritis for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Migraine for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Ophthalmic Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
United States (US) Non-steroidal Anti-inflammatory Drugs Import Export Trade Statistics
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By Disease Indication
Market Opportunity Assessment By Distribution Channel
United States (US) Non-steroidal Anti-inflammatory Drugs Top Companies Market Share
United States (US) Non-steroidal Anti-inflammatory Drugs Competitive Benchmarking By Technical and Operational Parameters
United States (US) Non-steroidal Anti-inflammatory Drugs Company Profiles
United States (US) Non-steroidal Anti-inflammatory Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle

3.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces

3.5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.6 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases such as arthritis and musculoskeletal disorders

4.2.2 Growing geriatric population in the United States

4.2.3 Rising awareness about the benefits of non-steroidal anti-inflammatory drugs (NSAIDs) for pain management

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval and marketing

4.3.2 Potential side effects associated with long-term use of NSAIDs

4.3.3 Presence of alternative therapies and treatments for pain management

5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Trends

6 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Types

6.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration

6.1.1 Overview and Analysis

6.1.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2021- 2031F

6.1.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.1.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F

6.1.5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2021- 2031F

6.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2021- 2031F

6.2.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2021- 2031F

6.2.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2021- 2031F

6.2.5 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.3.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3.4 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 United States (US) Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics

7.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries

7.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries

8 United States (US) Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators

8.1 Number of prescriptions for NSAIDs issued by healthcare providers

8.2 Patient adherence rates to NSAID treatment regimens

8.3 Frequency of recommendations for NSAIDs in clinical practice

9 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment

9.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 United States (US) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape

10.1 United States (US) Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Non-steroidal Anti-inflammatory Drugs Market

Eritrea Non-steroidal Anti-inflammatory Drugs Market

Estonia Non-steroidal Anti-inflammatory Drugs Market

Ethiopia Non-steroidal Anti-inflammatory Drugs Market

Fiji Non-steroidal Anti-inflammatory Drugs Market

Finland Non-steroidal Anti-inflammatory Drugs Market

Global Non-steroidal Anti-inflammatory Drugs Market

Middle East Non-steroidal Anti-inflammatory Drugs Market

North America Non-steroidal Anti-inflammatory Drugs Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here